Suppr超能文献

对澳大利亚医用大麻使用者的调查。

Survey of Australians using cannabis for medical purposes.

作者信息

Swift Wendy, Gates Peter, Dillon Paul

机构信息

National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, 2052, Australia.

出版信息

Harm Reduct J. 2005 Oct 4;2:18. doi: 10.1186/1477-7517-2-18.

Abstract

BACKGROUND

The New South Wales State Government recently proposed a trial of the medical use of cannabis. Australians who currently use cannabis medicinally do so illegally and without assurances of quality control. Given the dearth of local information on this issue, this study explored the experiences of medical cannabis users.

METHODS

Australian adults who had used cannabis for medical purposes were recruited using media stories. A total of 147 respondents were screened by phone and anonymous questionnaires were mailed, to be returned by postage paid envelope.

RESULTS

Data were available for 128 participants. Long term and regular medical cannabis use was frequently reported for multiple medical conditions including chronic pain (57%), depression (56%), arthritis (35%), persistent nausea (27%) and weight loss (26%). Cannabis was perceived to provide "great relief" overall (86%), and substantial relief of specific symptoms such as pain, nausea and insomnia. It was also typically perceived as superior to other medications in terms of undesirable effects, and the extent of relief provided. However, nearly one half (41%) experienced conditions or symptoms that were not helped by its use. The most prevalent concerns related to its illegality. Participants reported strong support for their use from clinicians and family. There was almost universal interest (89%) in participating in a clinical trial of medical cannabis, and strong support (79%) for investigating alternative delivery methods.

CONCLUSION

Australian medical cannabis users are risking legal ramifications, but consistent with users elsewhere, claim moderate to substantial benefits from its use in the management of their medical condition. In addition to strong public support, medical cannabis users show strong interest in clinical cannabis research, including the investigation of alternative delivery methods.

摘要

背景

新南威尔士州政府最近提议对大麻的医疗用途进行试验。目前在澳大利亚,将大麻用于医疗目的属于非法行为,且无法保证质量控制。鉴于当地在这个问题上缺乏相关信息,本研究探讨了医用大麻使用者的经历。

方法

通过媒体报道招募曾将大麻用于医疗目的的澳大利亚成年人。通过电话对总共147名受访者进行筛选,并邮寄匿名问卷,问卷通过邮资已付的信封返还。

结果

有128名参与者的数据可供分析。经常有报告称,长期且规律地使用医用大麻用于多种医疗状况,包括慢性疼痛(57%)、抑郁症(56%)、关节炎(35%)、持续性恶心(27%)和体重减轻(26%)。总体而言,大麻被认为能带来“极大缓解”(86%),并能显著缓解疼痛、恶心和失眠等特定症状。在不良影响以及缓解程度方面,它通常也被认为优于其他药物。然而,近一半(41%)的人经历了使用大麻并未改善的状况或症状。最普遍的担忧与大麻的非法性有关。参与者报告称,临床医生和家人对他们使用大麻给予了大力支持。几乎所有人都有兴趣(89%)参与医用大麻的临床试验,并且大力支持(79%)研究替代给药方式。

结论

澳大利亚的医用大麻使用者面临法律后果风险,但与其他地方的使用者一样,声称在使用大麻管理自身医疗状况方面有中度到显著的益处。除了公众的大力支持外,医用大麻使用者对临床大麻研究表现出浓厚兴趣,包括对替代给药方式的研究。

相似文献

引用本文的文献

本文引用的文献

7
Mental health of teenagers who use cannabis. Results of an Australian survey.
Br J Psychiatry. 2002 Mar;180:216-21. doi: 10.1192/bjp.180.3.216.
8
Who is using cannabis as a medicine and why: an exploratory study.
J Psychoactive Drugs. 2000 Oct-Dec;32(4):435-43. doi: 10.1080/02791072.2000.10400245.
9
The THC content of cannabis in Australia: evidence and implications.澳大利亚大麻中的四氢大麻酚含量:证据与启示
Aust N Z J Public Health. 2000 Oct;24(5):503-8. doi: 10.1111/j.1467-842x.2000.tb00500.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验